Mach7 Technologies Ltd
ASX:M7T

Watchlist Manager
Mach7 Technologies Ltd Logo
Mach7 Technologies Ltd
ASX:M7T
Watchlist
Price: 0.387 AUD -0.77% Market Closed
Market Cap: AU$90.9m

Mach7 Technologies Ltd
Investor Relations

Mach7 Technologies Ltd. provides medical imaging software and services for healthcare institutions. The company is headquartered in Melbourne, Victoria and currently employs 90 full-time employees. The company went IPO on 2005-11-30. The principal activities of the Company include the provision of enterprise imaging data sharing, storage and interoperability for healthcare enterprises globally. The firm operates through two segments: sale of software and rendering of professional services. The sale of software segment engaged in selling software licenses. The provision of the software license is a distinct performance obligation as the customer can derive substantial benefits from the license on its own when the license is delivered and installed. Healthcare enterprises globally segment engaged in providing professional services, such as implementation, training and annual support services. The firm provides various solutions, including Enterprise Diagnostic Viewing, Enterprise Data Management and Enterprise PACS.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Jan 29, 2026
AI Summary
Q2 2026

ARR Stability: Annual recurring revenue stayed steady at $23 million, showing strength in Mach7's subscription and maintenance base.

CARR Reduction: Contracted annual recurring revenue declined to $26.1 million, mainly due to dropping the NTP project but partially offset by new sales.

Cash Flow Turnaround: Operating cash flow turned positive for Q2, with $7.9 million in cash receipts catching up on delayed renewals and invoices.

Cost Controls: Total payments fell 9% year-over-year and 6% quarter-over-quarter, reflecting benefits from cost reduction initiatives.

Product Launch: Launched Flamingo architecture, secured first customer, and generated new high-quality sales leads.

Geographic Focus: Shifting commercial and sales focus towards Asia and the Middle East, with encouraging customer feedback and team expansion in those regions.

Execution Overhaul: Company continues executing its strategic reset, prioritizing profitable customer relationships and culture change focused on accountability and customer-centricity.

Balanced Investment: Increased marketing output and development capacity through partnerships and hiring in Malaysia, without materially raising costs.

Key Financials
Annual Recurring Revenue
$23 million
Contracted Annual Recurring Revenue
$26.1 million
Sales Orders
$6.8 million
New Sales
$3.1 million
Renewals
$2.9 million
Add-ons and Expansions
$0.9 million
Operating Cash Flow
Positive for Q2
Cash Receipts from Customers
$7.9 million
Total Payments
$7.9 million
Advertising and Marketing Spend
$0.4 million
Cash Balance
$18.5 million
Debt
$0
Earnings Call Recording
Other Earnings Calls

Management

Mr. Michael Lampron
CEO, MD & Director
No Bio Available
Ms. Dyan O'Herne
Chief Financial Officer
No Bio Available
Mr. David Madaffri
Chief Operating Officer
No Bio Available
Francoise Dixon
Head of Investor Relations
No Bio Available
Mr. Bob Tranchida
Vice President of Marketing
No Bio Available
Ms. Kelly Kimball
Vice President of People & Culture
No Bio Available
Mr. Anthony W. Panther A.C.I.S., AGIA, B.E., C.A., L.L.B., LL.B
Company Secretary
No Bio Available

Contacts

Address
VICTORIA
Melbourne
L 1 61 Spring Street
Contacts
+61392867500.0
www.mach7t.com